Search details
1.
Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis.
Nature
; 579(7798): 279-283, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32132708
2.
Metabolic control analysis of hepatic glycogen synthesis in vivo.
Proc Natl Acad Sci U S A
; 117(14): 8166-8176, 2020 04 07.
Article
in English
| MEDLINE | ID: mdl-32188779
3.
Characteristics of patients aged over 75Ā years with hepatitis C virus infection treated with direct-acting antivirals in Japan: Evidence based on the nationwide, real-world database in Japan.
Hepatol Res
; 51(4): 417-425, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33217105
4.
Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis.
Int J Mol Sci
; 21(6)2020 Mar 11.
Article
in English
| MEDLINE | ID: mdl-32168769
5.
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
J Gastroenterol Hepatol
; 34(9): 1626-1632, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-30668889
6.
Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis.
Carcinogenesis
; 38(3): 261-270, 2017 03 01.
Article
in English
| MEDLINE | ID: mdl-28426876
7.
Accuracy analysis of intrahepatic fat density measurements using dual-energy computed tomography: Validation using a test phantom.
J Xray Sci Technol
; 25(3): 403-415, 2017.
Article
in English
| MEDLINE | ID: mdl-27911350
8.
Hepatitis B virus vaccination-related seroprevalence among health-care personnel in a Japanese tertiary medical center.
Hepatol Res
; 46(13): 1330-1337, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-26931185
9.
Pathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism.
Liver Int
; 35(3): 1095-102, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-24620780
10.
Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution.
BMC Gastroenterol
; 15: 177, 2015 Dec 17.
Article
in English
| MEDLINE | ID: mdl-26678309
11.
Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.
BMC Gastroenterol
; 15: 42, 2015 Apr 01.
Article
in English
| MEDLINE | ID: mdl-25881230
12.
Abdominal visceral fat accumulation measured by computed tomography associated with an increased risk of gallstone disease.
J Gastroenterol Hepatol
; 30(8): 1325-31, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25869941
13.
Novel findings for the development of drug therapy for various liver diseases: Liver microsomal triglyceride transfer protein activator may be a possible therapeutic agent in non-alcoholic steatohepatitis.
J Pharmacol Sci
; 115(3): 270-3, 2011.
Article
in English
| MEDLINE | ID: mdl-21350309
14.
Serum nitric oxide metabolite as a biomarker of visceral fat accumulation: clinical significance of measurement for nitrate/nitrite.
Med Sci Monit
; 17(3): CR123-31, 2011 Feb 25.
Article
in English
| MEDLINE | ID: mdl-21358598
15.
FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic.
Life (Basel)
; 11(2)2021 Feb 14.
Article
in English
| MEDLINE | ID: mdl-33672864
16.
Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography.
Radiology
; 256(2): 640-7, 2010 Aug.
Article
in English
| MEDLINE | ID: mdl-20529989
17.
Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.
Mol Carcinog
; 49(7): 662-71, 2010 Jul.
Article
in English
| MEDLINE | ID: mdl-20564343
18.
Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis.
Hepatology
; 50(3): 772-80, 2009 Sep.
Article
in English
| MEDLINE | ID: mdl-19650159
19.
Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model.
Alcohol Clin Exp Res
; 34 Suppl 1: S18-24, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-18986378
20.
Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation.
Dig Dis Sci
; 55(3): 808-14, 2010 Mar.
Article
in English
| MEDLINE | ID: mdl-19267193